a developer of therapies for urological pathologies
Industry Biotechnology
A.I.dvisor indicates that over the last year, URGN has been loosely correlated with RNA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if URGN jumps, then RNA could also see price increases.
Ticker / NAME | Correlation To URGN | 1D Price Change % | ||
---|---|---|---|---|
URGN | 100% | -2.47% | ||
RNA - URGN | 37% Loosely correlated | -4.82% | ||
SPRB - URGN | 32% Poorly correlated | +1.92% | ||
LGVN - URGN | 32% Poorly correlated | -1.89% | ||
MREO - URGN | 32% Poorly correlated | -5.68% | ||
IDYA - URGN | 29% Poorly correlated | -3.35% | ||
More |
Ticker / NAME | Correlation To URGN | 1D Price Change % |
---|---|---|
URGN | 100% | -2.47% |
therapy theme (23 stocks) | 36% Loosely correlated | -3.44% |
drugs theme (254 stocks) | 29% Poorly correlated | -1.67% |
urology theme (3 stocks) | 23% Poorly correlated | -0.97% |
biotechnology theme (238 stocks) | 20% Poorly correlated | -1.76% |